S&P 500 7,580.07 −1.82%
Nasdaq 25,437.00 −2.86%
S&P/TSX 35,620.03 −1.74%
Apple 344.63 −1.23%
Nvidia 204.64 −4.22%
Microsoft 521.91 −1.55%
Shopify 220.37 −5.70%
Royal Bank 283.93 −1.49%
CAD/USD 0.7158 +0.11%
CLOSED · 10:50 ET
Market ClerkRecap
Sun Nov 1 · markets closed1 signal on Oct 31129 insider buys this week · $10BCIRO short report next: Nov 15The week ahead

GYRE

GYRE THERAPEUTICS, INC.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
4.56
−1.85 −28.86%
USD · close Oct 30

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $508.5MP/E —DIV YIELD —FCF YIELD -1.20%REV TTM $119.4M +13.5%NET INCOME −$28.2M −558.6%NET CASH $43.3M52W 4.56 – 8.76SEC XBRL · TTM TO Invalid Date

Congress is trading it

STOCK ACT DISCLOSURES
No STOCK Act disclosure names GYRE.

The STOCK Act allows 45 days to disclose; a lag over that is shown in red. Amounts are the ranges members report. Every member, every trade.

Watch GYRE. Know when insiders buy.
One email the day a filing lands. Free.